502 related articles for article (PubMed ID: 16881430)
21. Transtympanic gentamicin treatment using Silverstein MicroWick in Ménière's disease patients: long term outcome.
Suryanarayanan R; Srinivasan VR; O'Sullivan G
J Laryngol Otol; 2009 Jan; 123(1):45-9. PubMed ID: 18533050
[TBL] [Abstract][Full Text] [Related]
22. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.
Hsieh LC; Lin HC; Tsai HT; Ko YC; Shu MT; Lin LH
Acta Otolaryngol; 2009 Dec; 129(12):1420-4. PubMed ID: 19922092
[TBL] [Abstract][Full Text] [Related]
23. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
Boleas-Aguirre MS; Sánchez-Ferrandiz N; Guillén-Grima F; Perez N
Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149
[TBL] [Abstract][Full Text] [Related]
24. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
[TBL] [Abstract][Full Text] [Related]
25. Intratympanic gentamicin therapy for intractable Ménière's disease.
De Beer L; Stokroos R; Kingma H
Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229
[TBL] [Abstract][Full Text] [Related]
26. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
Kyrodimos E; Aidonis I; Sismanis A
J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
[TBL] [Abstract][Full Text] [Related]
27. Intratympanic gentamicin: a 1-day protocol treatment for unilateral Meniere's disease.
De Stefano A; Dispenza F; De Donato G; Caruso A; Taibah A; Sanna M
Am J Otolaryngol; 2007; 28(5):289-93. PubMed ID: 17826528
[TBL] [Abstract][Full Text] [Related]
28. [Intratympanic gentamicin treatment for intractable Menière's disease].
Gilony D; Wolf M; Kronenberg J
Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278
[TBL] [Abstract][Full Text] [Related]
29. Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes.
Smith WK; Sandooram D; Prinsley PR
J Laryngol Otol; 2006 Sep; 120(9):730-5. PubMed ID: 16848921
[TBL] [Abstract][Full Text] [Related]
30. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
Akkuzu B; Ozgirgin N; Ozlüoğlu LN
Kulak Burun Bogaz Ihtis Derg; 2006; 16(5):193-9. PubMed ID: 17124437
[TBL] [Abstract][Full Text] [Related]
31. Middle ear exploration in patients with Ménière's disease who have failed outpatient intratympanic gentamicin therapy.
Crane BT; Minor LB; Della Santina CC; Carey JP
Otol Neurotol; 2009 Aug; 30(5):619-24. PubMed ID: 19503016
[TBL] [Abstract][Full Text] [Related]
32. Treatment of intractable Menière's disease with intratympanic gentamicin: review of the University of Ottawa experience.
Corsten M; Marsan J; Schramm D; Robichaud J
J Otolaryngol; 1997 Dec; 26(6):361-4. PubMed ID: 9438932
[TBL] [Abstract][Full Text] [Related]
33. Intratympanic steroid injections for intractable Ménière's disease.
Barrs DM; Keyser JS; Stallworth C; McElveen JT
Laryngoscope; 2001 Dec; 111(12):2100-4. PubMed ID: 11802004
[TBL] [Abstract][Full Text] [Related]
34. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
Convert C; Franco-Vidal V; Bebear JP; Darrouzet V
Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
[TBL] [Abstract][Full Text] [Related]
35. Long-term results after interval therapy with intratympanic gentamicin for Menière's disease.
Lange G; Maurer J; Mann W
Laryngoscope; 2004 Jan; 114(1):102-5. PubMed ID: 14710003
[TBL] [Abstract][Full Text] [Related]
36. Reliability of the vestibular evoked myogenic potential test in assessing intratympanic gentamicin therapy in Meniere's disease.
Ozluoglu LN; Akkuzu G; Ozgirgin N; Tarhan E
Acta Otolaryngol; 2008 Apr; 128(4):422-6. PubMed ID: 18368577
[TBL] [Abstract][Full Text] [Related]
37. Menière's disease and gentamicin: preliminary results using the minimum effective dose and integrated therapy.
Sala T
Acta Otorhinolaryngol Ital; 2003 Apr; 23(2):78-87. PubMed ID: 14526554
[TBL] [Abstract][Full Text] [Related]
38. Use of the round window microcatheter in the treatment of Meniere's disease.
Hoffer ME; Kopke RD; Weisskopf P; Gottshall K; Allen K; Wester D; Balaban C
Laryngoscope; 2001 Nov; 111(11 Pt 1):2046-9. PubMed ID: 11801994
[TBL] [Abstract][Full Text] [Related]
39. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
Garduño-Anaya MA; Couthino De Toledo H; Hinojosa-González R; Pane-Pianese C; Ríos-Castañeda LC
Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
[TBL] [Abstract][Full Text] [Related]
40. Effects of a single intratympanic gentamicin injection on Meniere's disease.
Chung WH; Chung KW; Kim JH; Cho YS; Hong SH
Acta Otolaryngol Suppl; 2007 Oct; (558):61-6. PubMed ID: 17882572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
